
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to... FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.38 | 45.2380952381 | 0.84 | 1.3 | 0.7701 | 253347 | 0.97146325 | CS |
4 | 0.2 | 19.6078431373 | 1.02 | 1.3 | 0.7626 | 180660 | 0.93977038 | CS |
12 | -0.38 | -23.75 | 1.6 | 2 | 0.7626 | 305655 | 1.35430686 | CS |
26 | -2.23 | -64.6376811594 | 3.45 | 3.89 | 0.7626 | 224953 | 1.81242643 | CS |
52 | -9.77 | -88.8989990901 | 10.99 | 13.59 | 0.7626 | 265620 | 3.33443464 | CS |
156 | -28.78 | -95.9333333333 | 30 | 55 | 0.7626 | 237134 | 4.04516378 | CS |
260 | -28.78 | -95.9333333333 | 30 | 55 | 0.7626 | 237134 | 4.04516378 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions